GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brasil Pharma SA (BSP:BPHA3) » Definitions » Equity-to-Asset

Brasil Pharma (BSP:BPHA3) Equity-to-Asset : -4.15 (As of Mar. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Brasil Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Brasil Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2019 was R$-292.29 Mil. Brasil Pharma's Total Assets for the quarter that ended in Mar. 2019 was R$70.49 Mil. Therefore, Brasil Pharma's Equity to Asset Ratio for the quarter that ended in Mar. 2019 was -4.15.

The historical rank and industry rank for Brasil Pharma's Equity-to-Asset or its related term are showing as below:

BSP:BPHA3's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.46
* Ranked among companies with meaningful Equity-to-Asset only.

Brasil Pharma Equity-to-Asset Historical Data

The historical data trend for Brasil Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brasil Pharma Equity-to-Asset Chart

Brasil Pharma Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.46 0.23 0.21 -9.09 -3.72

Brasil Pharma Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.40 -17.14 -19.65 -3.72 -4.15

Competitive Comparison of Brasil Pharma's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Brasil Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brasil Pharma's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Brasil Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Brasil Pharma's Equity-to-Asset falls into.



Brasil Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Brasil Pharma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Equity to Asset (A: Dec. 2018 )=Total Stockholders Equity/Total Assets
=-268.383/72.15
=-3.72

Brasil Pharma's Equity to Asset Ratio for the quarter that ended in Mar. 2019 is calculated as

Equity to Asset (Q: Mar. 2019 )=Total Stockholders Equity/Total Assets
=-292.294/70.49
=-4.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brasil Pharma  (BSP:BPHA3) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Brasil Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Brasil Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Brasil Pharma Business Description

Traded in Other Exchanges
N/A
Address
Avenida Presidente Juscelino Kubitschek, 1,830, 3rd floor, Itaim Bibi, Sao Paulo, SP, BRA, 04543-900
Brasil Pharma SA is a Brazil-based company primarily engaged in the pharmaceutical retail sector. The company operates in the retail sale of medicines, perfumes, cosmetics, skincare and beauty products and toiletries. The operating segments of the company are Retail sector and Service sector, of which majority of the revenue is generated from the Retail segment. The group has its presence in all the regions of Brazil through its own stores and a franchise network. The owned stores of the company are operated under the Big Ben, Guararapes, District Pharmacy Rosary, Sant'Ana and Mais Economica brands. The company's franchises operate under the Farmais brand.

Brasil Pharma Headlines

No Headlines